The SPTLC1 gene helps your body make certain fats that nerve cells need to build healthy membranes and send signals. When this gene does not work properly, abnormal fats may form and damage nerves. People with harmful variants in the SPTLC1 gene may develop numbness, burning pain, weakness, or reduced feeling in the hands and feet, and some variants are linked to childhood muscle weakness or motor neuron disease. Many variants are harmless, while a few may change how the gene works.
What is a gene?
A gene is a section of DNA that carries instructions cells use to make molecules or regulate processes in the body. Some genes provide the directions for producing proteins, which are the parts of cells that do the work. Others are used mainly to guide when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body grows and works, and they can also influence how you respond to food, stress, or medications. To go deeper into this topic, you can find more in the LearnHub.
Overview
SPTLC1Gene function
What if the gene works
The SPTLC1 gene helps start production of sphingolipids, fats that support cell membranes and cell signaling. This is especially important for healthy nerve cells and their long nerve fibers.
Risk
What if the gene does not work
Variants in the SPTLC1 gene can cause inherited nerve conditions, most often hereditary sensory and autonomic neuropathy, with numbness, pain, and weakness. Some variants are linked to juvenile amyotrophic lateral sclerosis. Milder and severe variants can influence onset and features.
Treatment
What does that mean for your treatment
No treatment or drug choice specific to the SPTLC1 gene is currently established in clinical guidelines. In hereditary sensory neuropathy linked to the SPTLC1 gene, L-serine is being studied and sometimes used to lower harmful lipid byproducts, but this remains a targeted approach under specialist care rather than a standard treatment for all conditions linked to the SPTLC1 gene.
Conditions associated with SPTLC1
Gene function
What if the gene works
Your cells use the SPTLC1 gene to make certain fats they need every day. These fats, called sphingolipids, help build cell membranes and support cell signaling. Understanding what the SPTLC1 gene does helps explain how cells keep their membranes stable and organized.
The SPTLC1 gene helps your cells begin making sphingolipids (special fats used in membranes and signaling). It carries out the first major step, giving cells the starting material they need.
These sphingolipids become part of the outer layer around cells and the membranes inside them. This helps cells keep their shape, organize important proteins, and maintain steady everyday function.
Sphingolipids made with help from this gene also act as messengers inside the body. They help cells send and receive signals involved in growth, survival, and normal responses to changing conditions.
Inside the endoplasmic reticulum (a membrane network in cells), SPTLC1 works with partner proteins to run this process. This teamwork helps sphingolipid production stay coordinated and efficient.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and help explain normal human variation, such as appearance, metabolism, or the way the body responds to environmental influences. Many have no noticeable effect and are simply part of natural genetic diversity. In some situations, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SPTLC1 gene can change the enzyme’s shape or control signals, so it may use the wrong building blocks or stay too active. This helps explain how SPTLC1 gene variants influence function at the cellular level, often causing buildup of abnormal fats that can injure nerve cells. Some variants have a milder effect on enzyme activity, while more disruptive changes create larger shifts in fat production. In related nerve conditions, stronger functional changes may be linked to earlier or more severe features.
How variants are linked to conditions
Pathogenic variants in the SPTLC1 gene cause hereditary sensory and autonomic neuropathy type 1A, a rare inherited nerve condition marked by reduced pain sensation and progressive nerve damage. Other specific SPTLC1 gene variants are linked to juvenile amyotrophic lateral sclerosis, a form of ALS that begins in childhood or adolescence. These are well-established SPTLC1 related conditions, and the exact diagnosis depends on the particular variant.
A variant is not necessarily a diagnosis
DNA variants are a routine part of human biology and are common throughout the general population. Most have no direct impact on health and simply reflect normal human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the SPTLC1 gene. In families with a disease-causing SPTLC1 change, risk is mainly tied to the inherited variant itself, and personal guidance about monitoring is best discussed with a doctor or genetic counselor.
Inheritance of SPTLC1 variants
For families trying to understand how SPTLC1 gene variants are inherited, the best established pattern is autosomal dominant. This means a parent carrying a disease-causing variant in the SPTLC1 gene can pass it to a child, and each child has a 1 in 2, or 50%, chance of inheriting that same variant. Some people with an SPTLC1-related condition have a new variant that was not inherited from either parent.
What does my SPTLC1 result mean for my family?
For SPTLC1, family meaning is usually discussed in a dominant pattern: close relatives such as parents, brothers, sisters, and children may also carry the same gene change and may want to learn whether it is present in them too. In some families, the change is passed down through generations; in others, it can start new in one person, so a parent is not always the source. The exact family impact depends on the specific SPTLC1 result and the condition linked to it.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for SPTLC1 variants usually uses a blood or saliva sample. A lab reads the DNA code in the SPTLC1 gene and compares it with the usual sequence to look for variants. Results can help confirm whether an inherited nerve condition is present in a person or running in a family.
When should I consider getting a genetic test?
Consider testing for changes in the SPTLC1 gene if you or close relatives have an inherited nerve condition with numbness, burning pain, foot sores, or weakness that started early in life. It can also be relevant when there is unexplained young-onset muscle weakness or nerve disease running in the family.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals depends on the condition and the type of variant involved. Lifestyle, environment, age, and medical history, among other influences, all shape how the body functions over time. For some conditions, especially those affected by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This is common and helps explain why the same treatment works well for one person, has less effect in another, or causes more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes affect the way people respond to medicines. It focuses on gene-drug relationships to help explain why the same treatment can work differently in different people. For many drugs, genes can influence both how strongly a medicine works and how the body handles it. This information can support treatment choices that are more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the SPTLC1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work, so questions about side effects, new symptoms, or the best treatment for you are best discussed with your doctor or pharmacist.
History
Families affected by inherited numbness and pain loss were described long before the SPTLC1 gene was identified. In 2001, researchers linked variants in the SPTLC1 gene to hereditary sensory and autonomic neuropathy type 1, a key step in explaining a long-recognized inherited nerve condition. From these first observations, research expanded steadily. Scientists then connected different SPTLC1 variants with a broader range of nerve-related conditions, including some forms seen in childhood. Interest in the gene grew again in 2021 when newly identified variants were tied to juvenile amyotrophic lateral sclerosis, often called ALS. These findings made the SPTLC1 gene an important part of the modern history of inherited neurology.